Are you routinely using thrombopoietin agonists in patients with hep C and HCC?

Thrombocytopenia is a common issue in patients with advanced liver disease due to decreased thrombopoietin production and hypersplenism sequestration from portal hypertension. The degree of thrombocytopenia is often a maker of both severity of liver disease.

There are several TPO agonists on the mark...